KIT and squamous cell lung carcinoma: Importantly, the data also demonstrated the potential activation of STAT3 by a number of upstream receptor tyrosine kinase signaling pathways found to be recurrently amplified in squamous cell lung carcinoma, including PDGFRA and/or KIT, EGFR, and FGFR1.